UBS Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

UBS Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-201,839	Closed	-$33.3M	–	9469
2021 Q2	$33.3M	Buy	201,839 +26,439	+15%	+$4.37M	0.01%	823
2021 Q1	$26.9M	Buy	175,400 +142,480	+433%	+$21.8M	0.01%	913
2020 Q4	$4.13M	Sell	32,920 -25,306	-43%	-$3.17M	﹤0.01%	2019
2020 Q3	$5.91M	Buy	58,226 +24,856	+74%	+$2.52M	﹤0.01%	1588
2020 Q2	$3.25M	Sell	33,370 -85,938	-72%	-$8.36M	﹤0.01%	1909
2020 Q1	$9.91M	Buy	119,308 +17,740	+17%	+$1.47M	﹤0.01%	1104
2019 Q4	$11.3M	Buy	101,568 +35,000	+53%	+$3.89M	﹤0.01%	1422
2019 Q3	$6.61M	Buy	66,568 +27,564	+71%	+$2.73M	﹤0.01%	1649
2019 Q2	$3.87M	Sell	39,004 -24,898	-39%	-$2.47M	﹤0.01%	1997
2019 Q1	$7.05M	Buy	63,902 +14,871	+30%	+$1.64M	﹤0.01%	1563
2018 Q4	$4.51M	Sell	49,031 -22,342	-31%	-$2.05M	﹤0.01%	1780
2018 Q3	$7.87M	Buy	71,373 +9,627	+16%	+$1.06M	﹤0.01%	1565
2018 Q2	$5.77M	Sell	61,746 -16,733	-21%	-$1.56M	﹤0.01%	1761
2018 Q1	$6.51M	Sell	78,479 -49,313	-39%	-$4.09M	﹤0.01%	1666
2017 Q4	$11.6M	Buy	127,792 +43,040	+51%	+$3.92M	﹤0.01%	1241
2017 Q3	$6.46M	Buy	84,752 +4,996	+6%	+$381K	﹤0.01%	1555
2017 Q2	$5.98M	Sell	79,756 -33,248	-29%	-$2.49M	﹤0.01%	1559
2017 Q1	$7.37M	Buy	113,004 +38,976	+53%	+$2.54M	﹤0.01%	1370
2016 Q4	$4.08M	Sell	74,028 -4,781	-6%	-$264K	﹤0.01%	1750
2016 Q3	$4.45M	Sell	78,809 -17,224	-18%	-$973K	﹤0.01%	1625
2016 Q2	$4.01M	Buy	96,033 +45,397	+90%	+$1.9M	﹤0.01%	1666
2016 Q1	$2.17M	Buy	50,636 +3,621	+8%	+$155K	﹤0.01%	2081
2015 Q4	$2.13M	Sell	47,015 -12,547	-21%	-$568K	﹤0.01%	2138
2015 Q3	$2.31M	Sell	59,562 -2,324	-4%	-$90.2K	﹤0.01%	2034
2015 Q2	$2.25M	Buy	61,886 +11,199	+22%	+$407K	﹤0.01%	2209
2015 Q1	$1.46M	Sell	50,687 -5,432	-10%	-$157K	﹤0.01%	2521
2014 Q4	$1.36M	Buy	+56,119	New	+$1.36M	﹤0.01%	2544